Coriolis Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Coriolis Pharma's estimated annual revenue is currently $41.6M per year.
- Coriolis Pharma's estimated revenue per employee is $201,000
Employee Data
- Coriolis Pharma has 207 Employees.
- Coriolis Pharma grew their employee count by 25% last year.
Coriolis Pharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $89.4M | 445 | 9% | N/A | N/A |
#2 | $25.7M | 128 | -3% | N/A | N/A |
#3 | $41.6M | 207 | 25% | N/A | N/A |
#4 | $120.2M | 427 | 17% | $446.2M | N/A |
#5 | $44.4M | 221 | 46% | N/A | N/A |
#6 | $49.6M | 247 | 52% | N/A | N/A |
#7 | $21.9M | 109 | -1% | N/A | N/A |
#8 | $14.9M | 74 | -3% | N/A | N/A |
#9 | $26.7M | 133 | 25% | N/A | N/A |
#10 | $19.9M | 99 | 1% | N/A | N/A |
What Is Coriolis Pharma?
As a Contract Research Organization specialized in formulation development of (bio)pharmaceuticals such as proteins, peptides and vaccines Coriolis Pharma offers various services to support the development of your product: Analytical method development (aggregate and particle characterization, protein analytics, GMP analytics for MFI, light obscuration, HF5/AF4) Formulation research and development (from pre-formulation to market formulations) Forced degradation and stability testing (stress conditions tailored for the product, stability testing according ICH) Lyophilization (cycle development, scale up, modern PAT-tools) Supply pre-clinical material (GMP-like conditions in clean room)
keywords:N/AN/A
Total Funding
207
Number of Employees
$41.6M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Coriolis Pharma News
Luminex Corporation, Danaher Corporation, Merck Group, Coriolis Pharma, Sysmex, Agilent Technologies, Apogee, Thermo Fisher, Stratedigm. This...
Coriolis Pharma and U-Medico Form Alliance. To provide science-driven and innovative formulation development services for clients worldwide.